These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 31289352)

  • 1. Biomarker-guided therapy for colorectal cancer: strength in complexity.
    Sveen A; Kopetz S; Lothe RA
    Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
    Lin PS; Semrad TJ
    Methods Mol Biol; 2018; 1765():281-297. PubMed ID: 29589315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
    Siena S; Sartore-Bianchi A; Marsoni S; Hurwitz HI; McCall SJ; Penault-Llorca F; Srock S; Bardelli A; Trusolino L
    Ann Oncol; 2018 May; 29(5):1108-1119. PubMed ID: 29659677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
    Molloy MP; Engel A
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
    [No Abstract]   [Full Text] [Related]  

  • 5. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
    Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
    Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.
    Taieb J; Jung A; Sartore-Bianchi A; Peeters M; Seligmann J; Zaanan A; Burdon P; Montagut C; Laurent-Puig P
    Drugs; 2019 Sep; 79(13):1375-1394. PubMed ID: 31347092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and epigenomic biomarkers in colorectal cancer: From diagnosis to therapy.
    Ruiz-Bañobre J; Goel A
    Adv Cancer Res; 2021; 151():231-304. PubMed ID: 34148615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line therapy for metastatic colorectal cancer: Current perspectives and future directions.
    Burge M; Price T; Karapetis CS
    Asia Pac J Clin Oncol; 2019 Feb; 15 Suppl 1():3-14. PubMed ID: 30758881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.
    Henry JT; Johnson B
    Chin Clin Oncol; 2019 Oct; 8(5):49. PubMed ID: 31500426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of next-generation sequencing in colorectal cancers.
    Kim TM; Lee SH; Chung YJ
    World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
    Yarla NS; Madka V; Pathuri G; Rao CV
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
    Akkad J; Bochum S; Martens UM
    Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.
    Rodrigues D; Longatto-Filho A; Martins SF
    Biomed Res Int; 2016; 2016():6896024. PubMed ID: 27563673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.
    Mouillet-Richard S; Cazelles A; Sroussi M; Gallois C; Taieb J; Laurent-Puig P
    Clin Cancer Res; 2024 Jun; 30(11):2351-2358. PubMed ID: 38564259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
    Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
    Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning.
    Dienstmann R; Salazar R; Tabernero J
    Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualized therapy for metastatic colorectal cancer.
    Silvestri A; Pin E; Huijbers A; Pellicani R; Parasido EM; Pierobon M; Petricoin E; Liotta L; Belluco C
    J Intern Med; 2013 Jul; 274(1):1-24. PubMed ID: 23527888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
    Atreya CE; Yaeger R; Chu E
    Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Biomarkers: A Review of Multiple Applications in Clinical Care of Colorectal Cancer.
    Schmitt ML
    Clin J Oncol Nurs; 2020 Dec; 24(6):635-643. PubMed ID: 33216064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.